Myovant Sciences Ltd

MYOV

New York Stock Exchange. Currency in USD

26.84 -0.05 ( -0.19% )

Real time prices: December 19

Market Cap.
2.60B
Beta (5Y monthly)
2.22
Price/Earnings
-
EPS (TTM)
-2.00
Forward Dividend
0.00 (0.00%)
Ex-Dividend Date
Volume
338,800
1y Target Est.
27.00
Day's Range
26.82
-
26.87
52 Week's Range
7.67
-
26.97

Historical Summary

Performance
EPS growth
Share Buybacks

About Myovant Sciences Ltd

Sector
Healthcare
Industry
Biotechnology
Website
https://myovant.com
Exchange
New York Stock Exchange (XNYS)
Shares Outstanding
93.31M
Employees
579
Address
11-12 St. James?s Square, London, United Kingdom, SW1Y 4LB
Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain, and advanced prostate cancer. It is also developing MVT-602, an oligopeptide kisspeptin agonist, which is in Phase II clinical trial for the treatment of female infertility as part of assisted reproduction. Myovant Sciences Ltd. has collaboration with Pfizer Inc. to develop and commercialize relugolix in oncology and women's health. The company was formerly known as Roivant Endocrinology Ltd. and changed its name to Myovant Sciences Ltd. in May 2016. The company was incorporated in 2016 and is based in London, the United Kingdom. Myovant Sciences Ltd. is a subsidiary of Sumitovant Biopharma Ltd.

Latest news

Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08
Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08

BASEL, Switzerland, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV), a biopharmaceutical company...
By GlobeNewswire Inc. - 10 weeks ago

Myovant Sciences Appoints Ann Tomlin as Senior Vice President of Human Resources
Myovant Sciences Appoints Ann Tomlin as Senior Vice President of Human Resources

BASEL, Switzerland, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV) today announced the...
By GlobeNewswire Inc. - 10 weeks ago

Benzinga's Top Ratings Upgrades, Downgrades For October 26, 2022
Benzinga's Top Ratings Upgrades, Downgrades For October 26, 2022

Upgrades For Enterprise Financial Services Corp (NASDAQ:EFSC), DA Davidson upgraded the previous rating of Neutral...
By Benzinga - 13 weeks ago

Myovant Sciences (MYOV) Reports Q2 Loss, Tops Revenue Estimates
Myovant Sciences (MYOV) Reports Q2 Loss, Tops Revenue Estimates

Myovant Sciences (MYOV) delivered earnings and revenue surprises of 4.08% and 13.94%, respectively, for the...
By Zacks Investment Research - 13 weeks ago

Benzinga's Top Ratings Upgrades, Downgrades For October 25, 2022
Benzinga's Top Ratings Upgrades, Downgrades For October 25, 2022

Upgrades According to Wells Fargo, the prior rating for Weber Inc (NYSE:WEBR) was changed from...
By Benzinga - 13 weeks ago

Where Myovant Sciences Stands With Analysts
Where Myovant Sciences Stands With Analysts

Myovant Sciences (NYSE:MYOV) has observed the following analyst ratings within the last quarter: Bullish Somewhat...
By Benzinga - 13 weeks ago

US Stock Futures Down; Big Tech Earnings In Focus
US Stock Futures Down; Big Tech Earnings In Focus

Pre-open movers U.S. stock futures traded lower in early pre-market trade on Tuesday after recording...
By Benzinga - 14 weeks ago

Why Tricida Shares Dipped Around 95%; Here Are 73 Biggest Movers From Yesterday
Why Tricida Shares Dipped Around 95%; Here Are 73 Biggest Movers From Yesterday

Gainers Applied Genetic Technologies Corporation (NASDAQ: AGTC) climbed 62.4% to close at $0.39. Syncona disclosed...
By Benzinga - 14 weeks ago